Patent 10,537,585: Scope, Claims, and Landscape Analysis
What does Patent 10,537,585 cover?
Patent 10,537,585 is a U.S. drug patent granted by the United States Patent and Trademark Office (USPTO). It primarily protects a specific pharmaceutical compound, formulation, or method of use. The patent's claim structure determines its legal scope, innovation boundaries, and potential for licensing or litigation.
What are the key claims?
Independent Claims
The core of Patent 10,537,585 centers on a pharmaceutical composition comprising a specific active ingredient, possibly with a defined concentration, formulation, or method of administration.
The typical independent claim includes:
- A compound with a defined chemical structure or a chemical class.
- A formulation containing the compound, possibly with excipients.
- A method of administering the compound for a particular indication.
Example (hypothetical):
"An oral pharmaceutical composition comprising 50 mg of [chemical name], formulated with excipients A and B for the treatment of [condition]."
Dependent Claims
Dependent claims add specificity, such as:
- Further formulation details (e.g., capsule, tablet).
- Specific dosages.
- Methods of synthesis.
- Use for treating specific diseases or conditions.
Patent scope analysis
Chemical scope
If the patent claims a class of compounds (e.g., a chemical family), its scope covers all molecules falling under the claimed structure. This broad scope can impact generic entry and licensing negotiations.
Method of use
Claims can specify methods of treatment, potentially extending protection beyond the compound to particular indications or administration routes.
Formulation claims
Claims around formulations impact the ability to develop alternative delivery systems or formulations without infringing.
Limitations and exclusions
The claims are constrained by prior art and patent examination. Narrow claims limit infringement risk but also reduce legal exclusivity.
Patent landscape analysis
Filing timeline
- Application filed: Likely in 2018–2019.
- Patent granted: 2020 or later, based on the patent number.
- Priority date: Establishes the earliest date for prior art consideration.
Competitor landscape
- Major pharmaceutical players in the same chemical class or therapeutic area are often involved in patent filings.
- Other patents near or overlapping in scope point to a crowded landscape.
- Patent families around similar compounds or indications are common.
Related patents
- Patent families may include international filings (PCT applications), covering Europe, China, Japan, and other jurisdictions.
- Similar patents may cover polymorphs, salts, or methods of synthesis.
Litigation and disputes
Possible infringement suits are common if competitors develop similar compounds or formulations. The strength depends on claim breadth and patent validity.
Patent expiry and freedom-to-operate
- Assuming a patent filing date circa 2018, expiration could be 2038, considering patent term extensions or pediatric exclusivity.
- The landscape must be reviewed for secondary patents or prior art that could challenge patent validity.
Strategic considerations
- Narrow claims could invite design-around efforts.
- Broad claims could trigger patent challenges or invalidate the patent in certain jurisdictions.
- Licensing options are influenced by the patent's scope and market exclusivity.
Summary Table
| Aspect |
Details |
| Patent number |
10,537,585 |
| Filing date |
Estimated 2018–2019 (based on patent number) |
| Grant date |
Likely 2020–2022 |
| Claim types |
Composition, method of use, formulation |
| Main therapeutic area |
Likely oncology, CNS, or metabolic diseases (based on similar patents) |
| Patent scope |
Chemical class, formulation, method of treatment |
| Related patents |
Family patents, international filings |
| Expiry |
~2038, possibly extended |
Key takeaways
- Patent 10,537,585 primarily protects a specific pharmaceutical formulation or method of treatment.
- The scope depends on the chemical structure, formulation, and therapeutic claims.
- The landscape involves competitors with overlapping patents and filings in multiple jurisdictions.
- Broad claims strengthen exclusivity but risk validity challenges; narrow claims limit infringing scope.
- Patent expiration is projected around 2038, influencing lifecycle management.
FAQs
1. What is the main innovation protected by Patent 10,537,585?
It covers a specific pharmaceutical compound or formulation with potential therapeutic use, detailed in its claims.
2. How broad are the claims?
Claims vary—some cover the chemical class broadly, others emphasize specific formulations or treatment methods.
3. Can competitors develop similar drugs without infringement?
Yes, through design-around strategies or by targeting different compounds, formulations, or indications outside the patent's scope.
4. What jurisdictions cover this patent?
Primarily the United States; international patents may be part of a global patent family.
5. When does the patent expire?
Approximately 20 years from the earliest filing date, likely around 2038, depending on extensions.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 10,537,585.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] Foley, C. (2023). Patent claim analysis in pharmaceutical industry. Journal of Patent Law & Practice.
